ABOUT US A TRUSTED PARTNER IN GLOBAL HEALTH Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized the highest quality products to battle malaria and other serious diseases. We are a trusted partner to international public health agencies and organizations, including the World Health Organization, the Bill and Melinda Gates Foundation, UNICEF, and many others. Learn more PRODUCTS COVID-19 Diagnostic Tests Learn more Rapid Diagnostic Tests Learn more Analyzers Learn more Molecular Tests Learn more THE RANGE LEADING THE FIGHT AGAINST COVID-19 A challenge as complex as the Covid-19 pandemic requires innovative, adaptable solutions. To meet the need for accurate, reliable screening, we have a suite of products that includes PCR, serology, and antigen testing. Learn more NEWS December 17, 2020 MCKESSON MEDICAL SURGICAL SIGNS NATIONAL DISTRIBUTION AGREEMENT INTRIVO DIAGNOSTICS SECURES NATIONAL DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL-SURGICAL FOR ACCESS BIO CARESTART™ COVID-19 TESTS December 14, 2020 ANNOUNCEMENT OF THE RECORD DATE FOR DETERMINING SHAREHOLDERS In accordance with Article 16 (1) of the “Korean Depository Receipt Agreement” signed between Access Bio and Korea Securities Depository on March 11, 2013, the Record Date for determining shareholders in 2020 is December 31, 2020. December 03, 2020 CONCORDANCE HEALTHCARE SOLUTIONS AND NDC INK NATIONAL DISTRIBUTION AGREEMENTS Major supply chain agreements will ensure broad access to rapid testing solutions for patients and healthcare providers across US GLOBAL OPERATIONS AND REACH Learn more ACCESSBIO INVESTORS Learn more WE ARE HIRING Learn more GET IN TOUCH CONNECT WITH US HERE AND WE’LL BE TOUCH We are always seeking to collaborate with forward-thinking individuals, organizations, and institutions. COUNTRY?* USA South Korea All Other Countries INQUIRY PURPOSE?* Outside US Market Inside US Market Selling General Inquiry Product Inquiry HR Inquiry IR Inquiry Other PRODUCT?* COVID-19 DETECTION KITS RAPID DIAGNOSTIC TESTS ANALYZERS MOLECULAR DIAGNOSTICS 65 Clyde Rd. Suite A Somerset, NJ 08873 USA +1. 732.873.4040 E-mail : info@accessbio.net ABOUT US Overview Vision CEO Message Global Operations PRODUCTS Product List Covid-19 Tests Rapid Diagnostic Tests Analyzers Molecular Diagnostics NEWS News and Events CAREERS Open Positions INVESTORS Investors Relations Korean Investors LEGAL Privacy Policy Terms & Conditions The information, software, products, and services included in or available through the site may include inaccuracies or typographical errors. Changes are periodically added to the information herein. Access bio and/or its suppliers may make improvements and/or changes in the site at any time. Access bio and/or its suppliers make no representations about the suitability, reliability, availability, timeliness, and accuracy of the information, software, products, services and related graphics contained on the site for any purpose. To the maximum extent permitted by applicable law, all such information, software, products, services, and related graphics are provided “as is” without warranty or condition of any kind. © 2021 ACCESS BIO. ALL RIGHTS RESERVED. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All “On July 16, 2021, FDA granted an extension of the shelf-life of CareStartTM COVID-19 ANTIGEN point-of-care tests when stored at 1–30°C. Accordingly, certain CareStartTM COVID-19 ANTIGEN point-of-care tests that are currently labeled with expiration dates between February 2021 and July 2021 in fact have longer shelf lives than indicated by the expiration date on the label. A list of the affected lots can be found at the following link [link to the Attachment]. If you have any questions please contact us at info@accessbio.net. A copy of FDA’s letter to Access Bio regarding the shelf-life extension is available at the following link: https://www.fda.gov/media/150840/download.” ×